1. Home
  2. ASIX vs RZLT Comparison

ASIX vs RZLT Comparison

Compare ASIX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdvanSix Inc.

ASIX

AdvanSix Inc.

HOLD

Current Price

$15.68

Market Cap

460.1M

Sector

Industrials

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

BUY

Current Price

$3.85

Market Cap

471.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ASIX
RZLT
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.1M
471.0M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
ASIX
RZLT
Price
$15.68
$3.85
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
★ $20.00
$9.80
AVG Volume (30 Days)
212.4K
★ 1.7M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 4.08%
N/A
EPS Growth
11.11
★ 23.47
EPS
★ N/A
N/A
Revenue
★ $1,684,625,000.00
N/A
Revenue This Year
$9.86
N/A
Revenue Next Year
$5.06
$2,214.20
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 45.49
N/A
52 Week Low
$14.10
$1.07
52 Week High
$26.73
$11.46

Technical Indicators

Market Signals
Indicator
ASIX
RZLT
Relative Strength Index (RSI) 39.57 42.25
Support Level $15.46 $3.69
Resistance Level $16.93 $4.09
Average True Range (ATR) 0.44 0.34
MACD -0.05 -0.05
Stochastic Oscillator 30.73 30.84

Price Performance

Historical Comparison
ASIX
RZLT

About ASIX AdvanSix Inc.

AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: